TG Therapeutics director granted 8,325 stock units

Lonial Sagar reported acquisition or exercise transactions in this Form 4 filing.

Accepted by SEC EDGAR 06/15/2026 - 05:03 PM EDT Learn about SEC filing dates

Rhea-AI Filing Summary

Lonial Sagar reported acquisition or exercise transactions in this Form 4 filing.

TG Therapeutics director Sagar Lonial received a grant of 8,325 stock tracking units. Each unit is a contingent right to either one share of common stock or a cash payment equal to the fair market value of one share, generally within 30 days after the first anniversary of grant. The units vest on that first anniversary if he remains in continuous service, and this filing shows 8,325 units held after the grant.

Insider Trade Summary

Grant/Award: 8,325 shares

Grant/Award 1 txn

Insider Lonial Sagar

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Stock Tracking Unit	8,325	$0.00	$0.00

Holdings After Transaction: Stock Tracking Unit — 8,325 contracts (Direct)

Holdings Before and After: Stock Tracking Unit, 0 to 8,325 contracts (Direct)

Footnotes (2)

1. F1. Each stock tracking unit ("STU") represents a contingent right to receive either (determined at the sole discretion of the committee of the Board of Directors of the Issuer that administers the Issuer's 2022 Incentive Plan) (i) one share of the Issuer's common stock or (ii) a cash payment equal to the fair market value of one share of the Issuer's common stock, no later than thirty (30) days after the first anniversary of the date of grant.
2. F2. Provided the Reporting Person remains in continuous service with the Issuer through the vesting date, the STUs shall vest upon the first anniversary of the date of grant.

Key Figures

Stock tracking units granted: 8,325 units Underlying common shares: 8,325 shares Exercise/conversion price: $0.00 per unit +2 more

5 metrics

Stock tracking units granted 8,325 units Grant on 2026-06-11 to director Sagar Lonial

Underlying common shares 8,325 shares Each unit tied to one share of common stock

Exercise/conversion price $0.00 per unit Equity-based compensation grant, not a market purchase

Holdings after transaction 8,325 units Total stock tracking units following the grant

Vesting schedule 1-year Units vest on first anniversary if continuous service continues

Key Terms

Stock Tracking Unit, contingent right, fair market value, vesting, +1 more

5 terms

Stock Tracking Unit financial

"Each stock tracking unit ("STU") represents a contingent right to receive either..."

contingent right financial

"represents a contingent right to receive either (i) one share of the Issuer's common stock or (ii) a cash payment..."

fair market value financial

"a cash payment equal to the fair market value of one share of the Issuer's common stock"

The price a willing buyer and a willing seller would agree on for an asset or security when neither is under pressure and both have access to the same information. Think of it as the market’s neutral estimate of what something is worth, like the price two neighbors would settle on for a car after comparing similar listings. Investors care because fair market value guides buying and selling decisions, tax reporting, portfolio valuation, and how accurately company assets are reflected in financial statements.

vesting financial

"the STUs shall vest upon the first anniversary of the date of grant"

Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.

continuous service financial

"Provided the Reporting Person remains in continuous service with the Issuer through the vesting date"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did TG Therapeutics (TGTX) report for Sagar Lonial?

TG Therapeutics reported that director Sagar Lonial received a grant of 8,325 stock tracking units. These units are a form of equity-based compensation tied to the company’s common stock rather than an open-market stock purchase or sale.

What is a stock tracking unit in the TG Therapeutics (TGTX) Form 4?

A stock tracking unit is a contingent right that can become either one share of TG Therapeutics common stock or a cash payment equal to the fair market value of one share, as determined by the plan’s administering committee.

When do Sagar Lonial’s TG Therapeutics (TGTX) stock tracking units vest?

The stock tracking units are scheduled to vest on the first anniversary of the grant date. Vesting is conditioned on Sagar Lonial remaining in continuous service with TG Therapeutics through that one-year vesting date.

How many TG Therapeutics (TGTX) stock tracking units does Sagar Lonial hold after this grant?

After this award, the Form 4 shows that Sagar Lonial holds 8,325 stock tracking units. Each unit is tied to one underlying share of TG Therapeutics common stock or an equivalent cash value, depending on how the award is ultimately settled.

Is Sagar Lonial’s TG Therapeutics (TGTX) award a cash purchase or market trade?

No, the 8,325 stock tracking units were granted at a reported price of $0.00 per unit. This indicates a compensation grant under the company’s incentive plan, not an open-market stock purchase or sale for cash.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Lonial Sagar

(Last) (First) (Middle)

3020 CARRINGTON MILL BLVD, SUITE 475

(Street)

MORRISVILLE NORTH CAROLINA 27560

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
TG THERAPEUTICS, INC. [ TGTX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/11/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Tracking Unit	(1)	06/11/2026		A		8,325		(2)	(2)	Common Stock	8,325	$0	8,325	D

Explanation of Responses:

1. Each stock tracking unit ("STU") represents a contingent right to receive either (determined at the sole discretion of the committee of the Board of Directors of the Issuer that administers the Issuer's 2022 Incentive Plan) (i) one share of the Issuer's common stock or (ii) a cash payment equal to the fair market value of one share of the Issuer's common stock, no later than thirty (30) days after the first anniversary of the date of grant.

2. Provided the Reporting Person remains in continuous service with the Issuer through the vesting date, the STUs shall vest upon the first anniversary of the date of grant.

	/s/ Sagar Lonial	06/15/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)